Related Experiment Videos
Stimulus-driven versus pilocarpine-induced biometric changes in pseudophakic eyes
K Kriechbaum1, O Findl, C Koeppl
1Department of Ophthalmology, Medical University of Vienna, Vienna, Austria.
Ophthalmology
|March 5, 2005
Summary
Pilocarpine overestimates accommodative intraocular lens (IOL) movement compared to natural near-point stimulation. This study suggests pilocarpine may not accurately reflect daily performance but can assess maximum IOL potential.
Area of Science:
- Ophthalmology
- Biomedical Engineering
Background:
- Accommodative intraocular lenses (IOLs) aim to restore the eye's natural focusing ability.
- Current methods often use pilocarpine to induce ciliary muscle contraction for studying IOL movement, which may not reflect physiological conditions.
Purpose of the Study:
- To compare in vivo IOL movement induced by physiologic, stimulus-driven accommodation versus pilocarpine-induced accommodation.
- To evaluate the correlation between IOL movement and visual acuity.
Main Methods:
- A controlled, masked clinical trial involving 38 eyes with accommodating IOLs (1CU) and 28 control eyes with open-loop IOLs.
- Partial coherence interferometry was used to measure IOL position during near-point and pilocarpine stimulation.
- Visual acuity was assessed using logarithm of the minimum angle of resolution charts.
Main Results:
- Physiologic near-point accommodation did not induce significant IOL movement in either group.
- Pilocarpine induced a mean anterior movement of 0.201 mm in the 1CU IOLs (P<0.001), with no movement in controls.
- No significant correlation was found between IOL movement and distance-corrected near visual acuity (DCNVA).
Conclusions:
- Pilocarpine may act as a 'superstimulus,' potentially overestimating accommodative IOL movement compared to natural accommodation.
- The findings suggest pilocarpine may not adequately simulate the daily performance of accommodating IOLs.
- Pilocarpine may still be valuable for assessing the maximum potential range of accommodating IOLs.